MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Neurocognitive Functioning and Neurobehavioral Alterations in a Group of Patients Diagnosed with Idiopathic Parkinson’s Disease Without Dementia by Deep Brain Stimulation. Descriptive Study of the ESDEPARK Scale.

    C. Alberto Hurtado-González, J. Felipe Ayala-Rico, S. Ospina-Otalvaro, P. Gutiérrez-Lenis, A. Lucumi Moreno, M. Cañas-Lucendo, D. Reyes-Torres, L. Villegas-Trujillo, S. Ordoñez-Cure, K. Rivera-Quintero (Cali, Colombia)

    Objective: To identify the clinical correlation between neurocognitive functioning and depressive symptomatology in patients with IPDWD, assessed by a new scale (ESDEPARK) that measures depression…
  • 2025 International Congress

    Association Between Pesticide Exposure and Clinical Outcomes in Parkinson’s Disease: A Propensity-Matched Cohort Study

    C. Cerquera-Cleves, G. Pinilla-Monsalve, M. Blais, M. Cressati, C. Normandeau, C. Degroot, I. Kathol, S. Bogard, A. Bendas, R. Camicioli, Z. Gan-Or, DA. Grimes, K. Schoffer, LV. Kalia, PA. Macdonald, MJ. Mckeown, D. Martino, J. Miyasaki, M. Schlossmacher, AJ. Stoessl, A. Strafella, E. Fon, O. Monchi, N. Dupré, F. Cicchetti (Québec, Canada)

    Objective: To evaluate the clinical outcomes associated with pesticide exposure in Parkinson’s disease (PD) participants in the Canadian Open Parkinson Network (COPN)(1). Background: Pesticide exposure…
  • 2025 International Congress

    Age-related Trends in Amyloid Positivity in Parkinson’s Disease without Dementia

    K. Hatano, M. Kameyama, M. Kurihara, K. Ohse, R. Goto, R. Ihara, M. Higashihara, R. Sengoku, Y. Nishina, K. Kanemaru, Y. Saito, S. Murayama, A. Iwata (Tokyo, Japan)

    Objective: To identify the prevalence of amyloid positivity in patients with Parkinson’s disease (PD) without dementia in their eighties using CSF amyloid-beta 42 levels and…
  • 2025 International Congress

    Food-Related Predictors of Parkinson Progression

    L. Mischley, J. Farahnik, M. Murawska (Kenmore, USA)

    Objective: The goal of this study was to describe the current food-related behaviors associated with subsequent Parkinson disease (PD) symptom severity. Background: The Modifiable Variables…
  • 2025 International Congress

    The efficacy and safety of continuous subcutaneous infusion therapy with foslevodopa/foscarbidopa

    M. Shiraishi, N. Takao, Y. Nakano, Y. Yamano (Kawasaki City, Japan)

    Objective: To clarify the actual status of CSCI therapy, cases in which CSCI therapy was started at our hospital were investigated. Background: Continuous subcutaneous infusion…
  • 2025 International Congress

    A personalized gait signature assay in Parkinson’s disease

    H. Babcock, J. Stephen, V. Vanderhorst (Boston, USA)

    Objective: To establish a personalized gait signature assay to inform on progression, phenotype and effects of intervention of gait abnormalities in PD. Background: Gait signatures…
  • 2025 International Congress

    PREDIGT 2.0: A Self-Administered, Two-Step Screening Tool to Identify Individuals with Parkinson’s Disease

    J. Li, K. Grimes, J. Saade, N. Mauri, J. Tomlinson, A. Frank, D. Manuel, B. Mollenhauer, M. Schlossmacher (Ottawa, Canada)

    Objective: To pilot the 2-step PREDIGT Score model for feasibility and improve it by simplifying both steps. Background: We previously demonstrated that the original PREDIGT…
  • 2025 International Congress

    Force Estimation as a Method to Assess Proprioception in Parkinson’s Disease Patients

    M. Wilken, G. Bianchi, M. Martínez Sucre, C. Cruz Molina, G. Noel, D. Andres, M. Merello (Buenos Aires, Argentina)

    Objective: To evaluate the validity of force estimation as a method for assessing proprioception, and to determine if proprioception is impaired in Parkinson's disease (PD)…
  • 2025 International Congress

    A Study of Delayed Specialist Consultation in Parkinson’s Disease Patients in Uzbekistan

    L. Kenjaeva, B. Mukhammedaminov, N. Aripova, Y. Nishonova, G. Kendjaeva (Tashkent, Uzbekistan)

    Objective: Parkinson’s disease (PD) is a progressive neurodegenerative disorder where early diagnosis is crucial for preserving motor function and improving quality of life. However, in…
  • 2025 International Congress

    Impact of Innovative Physiotherapy Interventions on Motor Function and Quality of Life in Patients with Parkinson’s Disease and Movement Disorders

    E. Nakanwagi, G. Wangolo (KAMPALA, Uganda)

    Objective: 1. Assess the extent to which innovative physiotherapy interventions improve motor function, as measured by the Unified Parkinson’s Disease Rating Scale (UPDRS).2. Determine the…
  • « Previous Page
  • 1
  • …
  • 142
  • 143
  • 144
  • 145
  • 146
  • …
  • 181
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley